Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer (vol 24, pg 4840, 2006)

被引：1
|
作者：
Socinski
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 01期
关键词：
D O I：
10.1200/JCO.2007.11.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：167 / 167
页数：1
相关论文
共 50 条
  • [1] Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer
    Socinski, Mark A.
    Weissman, Charles
    Hart, Lowell L.
    Beck, J. Thaddeus
    Choksi, Janak K.
    Hanson, John P.
    Prager, Diane
    Monberg, Matthew J.
    Ye, Zhishen
    Obasaju, Coleman K.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) : 4840 - 4847
  • [2] Randomized phase II trial of pemetrexed with either cisplatin or carboplatin in extensive stage small cell lung cancer.
    Socinski, MA
    Weissman, C
    Hart, LL
    Choksi, JK
    Holladay, C
    Prager, D
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 667S - 667S
  • [3] Irinotecan, carboplatin, and bevacizumab in untreated extensive-stage small-cell lung cancer
    Spigel, David R.
    Hainsworth, John D.
    Burris, Howard A.
    Yardley, Denise A.
    Farley, Cindy
    Meng, Christina
    Greco, Anthony F.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S391 - S391
  • [4] Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: A phase II trial of the minnie pearl cancer research network
    Spigel, David R.
    Hainsworth, John D.
    Simons, Lisa
    Meng, Christina
    Burris, Howard A., III
    Yardley, Denise A.
    Grapski, Richard
    Schreeder, Marshall
    Mallidi, Padmaja V.
    Greco, F. Anthony
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (09) : 854 - 861
  • [5] Phase II Trial of Irinotecan, Carboplatin, and Bevacizumab in the Treatment of Patients with Extensive-Stage Small-Cell Lung Cancer
    Spigel, David R.
    Greco, F. Anthony
    Zubkus, John D.
    Murphy, Patrick B.
    Saez, Ruben A.
    Farley, Cindy
    Yardley, Denise A.
    Burris, Howard A., III
    Hainsworth, John D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) : 1555 - 1560
  • [6] A PHASE-II TRIAL OF CARBOPLATIN IN UNTREATED PATIENTS WITH EXTENSIVE STAGE SMALL-CELL LUNG-CANCER
    PALLARES, C
    IZQUIERDO, MA
    PAREDES, A
    SAGARRA, AF
    DEANDRES, L
    LOPEZ, JJL
    CANCER, 1991, 68 (01) : 40 - 43
  • [7] Randomized, phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated, extensive-stage, small-cell lung cancer (SCLC)
    Langer, C
    Hanna, N
    Einhorn, L
    Sandler, A
    Ansari, R
    Ellis, R
    Byrne, M
    Green, M
    Morrison, M
    Bunn, P
    LUNG CANCER, 2005, 49 : S53 - S54
  • [8] Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
    Hanna, N
    Bunn, PA
    Langer, C
    Einhorn, L
    Guthrie, T
    Beck, T
    Ansar, R
    Ellis, P
    Byrne, M
    Morrison, M
    Hariharan, S
    Wang, B
    Sandler, A
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) : 2038 - 2043
  • [9] Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study
    Ready, Neal E.
    Dudek, Arkadiusz Z.
    Pang, Herbert H.
    Hodgson, Lydia D.
    Graziano, Stephen L.
    Green, Mark R.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (33) : 4436 - 4441
  • [10] Phase 2 Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive-Stage Small Cell Lung Cancer, N0423
    Chee, Cheng E.
    Jett, James R.
    Bernath, Albert M., Jr.
    Foster, Nathan R.
    Nelson, Garth D.
    Molina, Julian
    Nikcevich, Daniel A.
    Steen, Preston D.
    Flynn, Patrick J.
    Rowland, Kendrith M., Jr.
    CANCER, 2010, 116 (10) : 2382 - 2389
12345